HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $8.99 billion. The enterprise value is $9.82 billion.
| Market Cap | 8.99B |
| Enterprise Value | 9.82B |
Important Dates
The next confirmed earnings date is Monday, December 9, 2024, after market close.
| Earnings Date | Dec 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 87.32 million shares outstanding. The number of shares has increased by 3.02% in one year.
| Current Share Class | 87.32M |
| Shares Outstanding | 87.32M |
| Shares Change (YoY) | +3.02% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 103.83% |
| Float | 85.85M |
Valuation Ratios
The trailing PE ratio is 85.84 and the forward PE ratio is 31.20. HealthEquity's PEG ratio is 1.27.
| PE Ratio | 85.84 |
| Forward PE | 31.20 |
| PS Ratio | 8.09 |
| Forward PS | 7.09 |
| PB Ratio | 4.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.46 |
| P/OCF Ratio | 29.22 |
| PEG Ratio | 1.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.11, with an EV/FCF ratio of 32.18.
| EV / Earnings | 92.94 |
| EV / Sales | 8.94 |
| EV / EBITDA | 29.11 |
| EV / EBIT | 54.81 |
| EV / FCF | 32.18 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.54.
| Current Ratio | 4.10 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 3.38 |
| Debt / FCF | 3.79 |
| Interest Coverage | 3.29 |
Financial Efficiency
Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 3.61%.
| Return on Equity (ROE) | 5.15% |
| Return on Assets (ROA) | 3.40% |
| Return on Capital (ROIC) | 3.61% |
| Revenue Per Employee | $348,930 |
| Profits Per Employee | $33,547 |
| Employee Count | 3,150 |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $24.99 million in taxes.
| Income Tax | 24.99M |
| Effective Tax Rate | 19.12% |
Stock Price Statistics
The stock price has increased by +52.96% in the last 52 weeks. The beta is 0.52, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +52.96% |
| 50-Day Moving Average | 86.66 |
| 200-Day Moving Average | 81.30 |
| Relative Strength Index (RSI) | 72.99 |
| Average Volume (20 Days) | 764,295 |
Short Selling Information
The latest short interest is 4.19 million, so 4.80% of the outstanding shares have been sold short.
| Short Interest | 4.19M |
| Short Previous Month | 4.41M |
| Short % of Shares Out | 4.80% |
| Short % of Float | 4.88% |
| Short Ratio (days to cover) | 8.61 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.10 billion and earned $105.67 million in profits. Earnings per share was $1.20.
| Revenue | 1.10B |
| Gross Profit | 713.69M |
| Operating Income | 179.19M |
| Pretax Income | 98.27M |
| Net Income | 105.67M |
| EBITDA | 337.43M |
| EBIT | 179.19M |
| Earnings Per Share (EPS) | $1.20 |
Balance Sheet
The company has $326.89 million in cash and $1.16 billion in debt, giving a net cash position of -$830.56 million or -$9.51 per share.
| Cash & Cash Equivalents | 326.89M |
| Total Debt | 1.16B |
| Net Cash | -830.56M |
| Net Cash Per Share | -$9.51 |
| Equity (Book Value) | 2.16B |
| Book Value Per Share | 24.70 |
| Working Capital | 374.72M |
Cash Flow
In the last 12 months, operating cash flow was $307.74 million and capital expenditures -$2.57 million, giving a free cash flow of $305.17 million.
| Operating Cash Flow | 307.74M |
| Capital Expenditures | -2.57M |
| Free Cash Flow | 305.17M |
| FCF Per Share | $3.49 |
Margins
Gross margin is 64.93%, with operating and profit margins of 16.30% and 9.61%.
| Gross Margin | 64.93% |
| Operating Margin | 16.30% |
| Pretax Margin | 11.89% |
| Profit Margin | 9.61% |
| EBITDA Margin | 30.70% |
| EBIT Margin | 16.30% |
| FCF Margin | 21.98% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.02% |
| Shareholder Yield | -3.02% |
| Earnings Yield | 1.18% |
| FCF Yield | 3.39% |
Analyst Forecast
The average price target for HealthEquity is $107.50, which is 4.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $107.50 |
| Price Target Difference | 4.41% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 3.58 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.58 |
| Piotroski F-Score | 7 |